Dermata Therapeutics (NASDAQ: DRMA)(NASDAQ: DRMAW) Closes Private Pl...

Dermata Therapeutics, Inc. (NASDAQ: DRMA)(NASDAQ: DRMAW), a late-stage biotechnology company dedicated to treating medical and aesthetic skin diseases...

Novartis’ Kisqali Cuts Breast Cancer Recurrence Risk by 28%

Headlines,Novartis’ Kisqali (ribociclib) demonstrated a 28.5% reduction in breast cancer recurrence risk when combined with endocrine therapy, accordi...

Labcorp Expands Services with Acquisition of BioReference Health

Headlines,Labcorp has completed its acquisition of BioReference Health’s assets, aimed at enhancing its laboratory services and testing capabilities a...

New Covid XEC variant spreads across Europe and beyond: what you nee...

As the Covid-19 pandemic continues to evolve, a new variant known as the Covid XEC variant is starting to spread rapidly across Europe, North America,...

Northwest Urgent Care (NYSE:CYH) Expands with Acquisition of 10 Ariz...

Northwest Urgent Care, LLC, a Tucson-based subsidiary of Community Health Systems, Inc. (NYSE:CYH), has announced a significant expansion through the...

Dermata Therapeutics (NASDAQ: DRMA, DRMAW) Secures $3.5 Million in P...

Dermata Therapeutics, Inc. (NASDAQ: DRMA, DRMAW), a late-stage biotechnology company specializing in medical and aesthetic skin treatments, has announ...

Direct tumor radiation: can pharma’s $10 billion bet transform cance...

Pharmaceutical heavyweights like Bristol Myers Squibb, AstraZeneca, and Eli Lilly are betting big on radiopharmaceuticals, investing over $10 billion...

Foghorn Therapeutics Sees Increase Amid High Trading Volume

In the,Healthcare sector,, Foghorn Therapeutics Inc. experienced a 9.5% increase in its share price, closing at $9.72 during the last trading session....

Recent Diagnostics Innovations Drive Company’s Success

In the,healthcare sector,, Abbott Laboratories has recently experienced noteworthy developments that underscore its continued strength in a key busine...

FDA Approves Roche's OCREVUS ZUNOVO for Multiple Sclerosis Treatment

In the,healthcare sector,, Swiss pharmaceutical company Roche has secured approval from the U.S. Food and Drug Administration (FDA) for its new treatm...

Factors Driving UnitedHealth’s Recent Stock Performance

UnitedHealth Group Incorporated has recently experienced an upward movement in its stock price, driven by several key factors within the,healthcare se...

GSK's Blood Cancer Drug Receives Breakthrough Therapy Designation

A major player of,Healthcare sector,, GSK PLC (,NYSE:GSK,) has received Breakthrough Therapy Designation (BTD) in China for its blood cancer medicatio...

Moderna (NASDAQ:MRNA) Plans Significant Cuts to R&D Spending, Eyes B...

In a strategic move aimed at optimizing financial performance, Moderna (NASDAQ:MRNA) has announced plans to cut its research and development (R&D) spe...

Moderna Restructures R&D Strategy, Anticipates $1.1B Savings

Headlines,- Moderna plans to streamline its research and development efforts, focusing on obtaining FDA approval for 10 key products.,- The company ex...

NHS’ ‘missing billions’: England’s healthcare is in emergency and St...

The dire state of England’s National Health Service (NHS) has been laid bare in a government-backed review led by former health minister Lord Ar...

Fulcrum Therapeutics stock tanks after Phase 3 trial failure of musc...

Fulcrum Therapeutics Inc. (NASDAQ: FULC) saw its stock plunge 65% on Thursday after announcing that its late-stage trial for losmapimod, a treatment f...

Why is Moderna’s stock crashing today? Here’s what we know

Moderna Inc. (NASDAQ: MRNA) saw its stock plunge more than 14% on Thursday, following the company’s announcement of significant cuts to its annual res...

GSK Advances mRNA Flu Vaccine to Phase III Trials After Positive Res...

GSK PLC, a major player in the,Healthcare sector,, has reported positive initial results from its seasonal flu vaccine using mRNA technology. The FTSE...

Futura Medical's Revenue Forecasts Upgraded Significantly

Futura Medical PLC, operating in the,healthcare sector,, has reported a substantial upgrade in its revenue forecasts following its latest interim resu...

Revolutionizing Wound Care: SOLV’s V.A.C. Peel and Place Dressing

Innovative Solution for Wound Therapy,SOLV's latest launch, the V.A.C. Peel and Place Dressing, addresses longstanding challenges in negative pressure...